Does REMIFENTANIL Cause Disseminated intravascular coagulation? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Disseminated intravascular coagulation have been filed in association with REMIFENTANIL (Remifentanil Hydrochloride). This represents 0.4% of all adverse event reports for REMIFENTANIL.
10
Reports of Disseminated intravascular coagulation with REMIFENTANIL
0.4%
of all REMIFENTANIL reports
3
Deaths
7
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From REMIFENTANIL?
Of the 10 reports, 3 (30.0%) resulted in death, 7 (70.0%) required hospitalization, and 6 (60.0%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMIFENTANIL. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does REMIFENTANIL Cause?
Anaphylactic shock (351)
Hypotension (195)
Anaphylactic reaction (178)
Cardiac arrest (145)
Bradycardia (132)
Foetal exposure during pregnancy (132)
Drug ineffective (112)
Off label use (109)
Anaesthetic complication neurological (96)
Premature baby (91)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which REMIFENTANIL Alternatives Have Lower Disseminated intravascular coagulation Risk?
REMIFENTANIL vs REMIMAZOLAM
REMIFENTANIL vs REMODULIN
REMIFENTANIL vs REPAGLINIDE
REMIFENTANIL vs REPOTRECTINIB
REMIFENTANIL vs REQUIP